Ping An Biomedical Co., Ltd. (PASW) — Cash Flow-to-Debt Ratio
Ping An Biomedical Co., Ltd. (PASW) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-6.43 Million could theoretically repay 0% of its total liabilities ($23.17 Million) in one year. See how financially flexible is Ping An Biomedical Co., Ltd. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ping An Biomedical Co., Ltd. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Ping An Biomedical Co., Ltd. across 5 annual periods. For the full cash flow conversion analysis, see PASW cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Ping An Biomedical Co., Ltd. (2021–2025)
Year-by-year debt coverage analysis for Ping An Biomedical Co., Ltd.. Check Ping An Biomedical Co., Ltd. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-6.43 Million | $23.17 Million | ▼ -221.4% |
| 2024 | 0.23x | $14.63 Million | $64.04 Million | ▲ +421.9% |
| 2023 | -0.07x | $-6.08 Million | $85.70 Million | ▼ -126.0% |
| 2022 | 0.27x | $21.09 Million | $77.35 Million | ▲ +165.8% |
| 2021 | -0.41x | $-31.37 Million | $75.77 Million | — |